Secondary Logo

Journal Logo

Reply to Goldsmith–Medical Marijuana in the Workforce

Phillips, Jennan A. PhD, MSN, RN; Holland, Michael G. MD; Baldwin, Debra D. NP-C, PhD; Meuleveld, Linda Gifford RN, COHN-S, CCM, CPDM; Mueller, Kathryn L. MD, MPH; Perkison, Brett MD, MPH; Upfal, Mark MD, MPH; Dreger, Marianne MA

Journal of Occupational and Environmental Medicine: November 2015 - Volume 57 - Issue 11 - p e140
doi: 10.1097/JOM.0000000000000595
LETTERS TO THE EDITOR
Free

Address correspondence to: Marianne Dreger, MA, ACOEM, Elk Grove Village, IL (mspraycar@gmail.com).

Readers are invited to submit letters for publication in this department. Submit letters online at http://joem.edmgr.com. Choose “Submit New Manuscript.” A signed copyright assignment and financial disclosure form must be submitted with the letter. Form available at www.joem.org under Author and Reviewer information.

To the Editor:

We believe that our article clearly asserts that best practice does not allow safety-sensitive employees to be under the influence of marijuana on the job; this could also be applied to all workers regardless of the safety sensitivity of their jobs as an employer's overarching policy. The Task Force was concerned that there are likely a number of people in the workplace who are impaired from prescribed substances and other causes who are currently not being identified. Thus, the article emphasizes the identification of impairment and the need for medical evaluation of such workers.

There are some data suggesting a small subset of chronic marijuana users may have less impairment than naive users at the same THC serum levels, due to tolerance. Previously published predictive models for estimating time since last use of marijuana (for estimating time of expected impairment after smoking), which were developed on testing of non-chronic users, are less accurate in daily cannabis users.1 It has been suggested that some of these individuals may not constitute a hazard for non–safety-sensitive work, and therefore individual evaluation for signs of impairment along with serum testing may be necessary.2 Naturally, employers involved in federal work or those who are legally allowed to forbid all marijuana use by their employees would not need to consider individual evaluation.

Back to Top | Article Outline

REFERENCES

1. Karschner EL, Schwope DM, Schwilke EW, et al. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. Drug Alcohol Depend 2012; 125:313–319.
2. Huestis MA. Cannabis-impaired driving: a public health and safety concern. Clin Chem. 2015. pii: clinchem.2015.245001. [Epub ahead of print].
Copyright © 2015 by the American College of Occupational and Environmental Medicine